Neumora Therapeutics, Inc.
NMRA
$1.28
-$0.12-8.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.88% | -8.16% | -12.08% | -6.89% | -10.91% |
| Total Receivables | -- | -- | 80.02% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.53% | 59.12% | -16.11% | -74.66% | 1,059.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -94.28% | 45.33% | 131.79% | -54.84% |
| Total Current Assets | -9.91% | -12.48% | -10.04% | -7.42% | -9.03% |
|
|
|||||
| Total Current Assets | -9.91% | -12.48% | -10.04% | -7.42% | -9.03% |
| Net Property, Plant & Equipment | -25.76% | -20.48% | -16.41% | -13.81% | -13.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Assets | -10.09% | -12.84% | -10.16% | -9.27% | -8.91% |
|
|
|||||
| Total Accounts Payable | -45.85% | 464.42% | -27.48% | 342.73% | -84.88% |
| Total Accrued Expenses | 8.06% | 24.34% | -6.10% | -8.30% | -8.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.50% | -23.90% | 3.32% | 3.35% | -0.59% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | -4.32% | -6.71% |
| Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | -4.32% | -6.71% |
| Total Current Liabilities | -5.85% | 37.27% | -6.03% | -2.00% | -13.78% |
|
|
|||||
| Total Current Liabilities | -5.85% | 37.27% | -6.03% | -2.00% | -13.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -49.38% | -32.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.00% | -38.20% | -27.05% | -21.29% | -17.55% |
| Total Liabilities | -5.94% | 36.98% | -9.56% | -5.35% | -15.40% |
|
|
|||||
| Common Stock & APIC | 2.08% | 0.98% | 1.31% | 0.79% | 5.86% |
| Retained Earnings | -6.62% | -8.89% | -7.75% | -7.64% | -18.28% |
| Treasury Stock & Other | -40.95% | 156.15% | -26.35% | -94.74% | 75.56% |
| Total Common Equity | -10.50% | -15.87% | -10.20% | -9.49% | -8.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.50% | -15.87% | -10.20% | -9.49% | -8.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.50% | -15.87% | -10.20% | -9.49% | -8.51% |
|
|
|||||
